Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MANIPALHOSNSE
MAXHEALTHNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 35% | 27% | 22% |
| - | - | 12% | 52% |
| - | - | - | -11% |
| 5% | 14% | 8% | 9% |
Peer Comparison
Symbol
APOLLOHOSP
MANIPALHOS
MAXHEALTH
ASTERDM
FORTIS
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 7,892 | ₹110240 Cr | 52.76 | 40.39 | 207.67 | ₹1942 Cr |
| 700.8 | ₹89900 Cr | 100.75 | 1.96 | 11.95 | ₹892 Cr |
| 883.15 | ₹85291 Cr | 58.54 | 3.31 | 19.84 | ₹1442 Cr |
| 683.15 | ₹59047 Cr | 185.29 | 0.31 | 6.76 | ₹388 Cr |
| 784.55 | ₹57679 Cr | 55.04 | 3.53 | 20.1 | ₹1042 Cr |
| 1,724.8 | ₹34558 Cr | 42.34 | 10.14 | 65.36 | ₹806 Cr |
| 1,306.6 | ₹34310 Cr | 61.69 | 5.91 | 29.85 | ₹556 Cr |
| 1,908.7 | ₹31877 Cr | 58.82 | 10.11 | 42.51 | ₹505 Cr |
| 703 | ₹28865 Cr | 141.29 | 1.04 | 12.74 | ₹241 Cr |
| 477 | ₹14907 Cr | 100.47 | 1.43 | 13.88 | ₹133 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| ₹614 Cr | ₹564 Cr | ₹530 Cr | ₹499 Cr | ₹487 Cr | ₹460 Cr | ₹431 Cr | ₹417 Cr | ₹403 Cr | ₹349 Cr | ₹333 Cr |
| ₹6 Cr | ₹13 Cr | ₹11 Cr | ₹8 Cr | ₹13 Cr | ₹15 Cr | ₹13 Cr | ₹12 Cr | ₹6 Cr | ₹20 Cr | ₹12 Cr |
| ₹620 Cr | ₹577 Cr | ₹540 Cr | ₹507 Cr | ₹501 Cr | ₹476 Cr | ₹443 Cr | ₹428 Cr | ₹409 Cr | ₹369 Cr | ₹345 Cr |
| ₹522 Cr | ₹479 Cr | ₹455 Cr | ₹430 Cr | ₹423 Cr | ₹390 Cr | ₹374 Cr | ₹367 Cr | ₹355 Cr | ₹288 Cr | ₹286 Cr |
| ₹177 Cr | ₹174 Cr | ₹155 Cr | ₹144 Cr | ₹141 Cr | ₹146 Cr | ₹128 Cr | ₹119 Cr | ₹110 Cr | ₹127 Cr | ₹101 Cr |
| ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹23 Cr | ₹25 Cr | ₹25 Cr | ₹28 Cr | ₹28 Cr | ₹27 Cr | ₹27 Cr | ₹22 Cr |
| ₹75 Cr | ₹77 Cr | ₹65 Cr | ₹54 Cr | ₹54 Cr | ₹59 Cr | ₹41 Cr | ₹33 Cr | ₹27 Cr | ₹54 Cr | ₹36 Cr |
| ₹55 Cr | ₹50 Cr | ₹44 Cr | ₹36 Cr | ₹38 Cr | ₹43 Cr | ₹28 Cr | ₹21 Cr | ₹18 Cr | ₹41 Cr | ₹23 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹32 Cr | ₹32 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| ₹12 Cr | ₹10 Cr | ₹6 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 |
| ₹1982 Cr | ₹1825 Cr | ₹1324 Cr | ₹620 Cr | ₹206 Cr | ₹177 Cr | ₹242 Cr |
| ₹1982 Cr | ₹1825 Cr | ₹1324 Cr | ₹620 Cr | ₹206 Cr | ₹177 Cr | ₹242 Cr |
| ₹2025 Cr | ₹1867 Cr | ₹1339 Cr | ₹630 Cr | ₹212 Cr | ₹184 Cr | ₹249 Cr |
| ₹94 Cr | ₹60 Cr | ₹40 Cr | ₹30 Cr | ₹21 Cr | ₹14 Cr | ₹18 Cr |
| ₹133 Cr | ₹157 Cr | ₹310 Cr | ₹306 Cr | ₹254 Cr | ₹168 Cr | ₹145 Cr |
| -₹26 Cr | -₹25 Cr | -₹35 Cr | -₹53 Cr | -₹13 Cr | -₹13 Cr | -₹11 Cr |
| ₹1203 Cr | ₹1084 Cr | ₹648 Cr | ₹546 Cr | ₹324 Cr | ₹265 Cr | ₹188 Cr |
| ₹24 Cr | ₹18 Cr | ₹14 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr |
| ₹1334 Cr | ₹1235 Cr | ₹937 Cr | ₹809 Cr | ₹572 Cr | ₹425 Cr | ₹327 Cr |
| — | — | — | — | — | — | — |
| ₹149 Cr | ₹127 Cr | ₹133 Cr | ₹101 Cr | ₹89 Cr | ₹75 Cr | ₹64 Cr |
| ₹280 Cr | ₹329 Cr | ₹233 Cr | ₹189 Cr | ₹95 Cr | ₹58 Cr | ₹64 Cr |
| ₹0 | ₹0 | ₹15 Cr | ₹5 Cr | ₹10 Cr | ₹10 Cr | ₹12 Cr |
| ₹32 Cr | ₹22 Cr | ₹19 Cr | ₹7 Cr | ₹12 Cr | ₹8 Cr | ₹6 Cr |
| ₹461 Cr | ₹478 Cr | ₹400 Cr | ₹301 Cr | ₹206 Cr | ₹150 Cr | ₹146 Cr |
| ₹3915 Cr | ₹3640 Cr | ₹2716 Cr | ₹1770 Cr | ₹1012 Cr | ₹774 Cr | ₹740 Cr |
| ₹68 Cr | ₹73 Cr | ₹19 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹8 Cr |
| ₹157 Cr | ₹247 Cr | ₹388 Cr | ₹356 Cr | ₹290 Cr | ₹185 Cr | ₹162 Cr |
| — | — | — | — | — | — | — |
| ₹3764 Cr | ₹3397 Cr | ₹2399 Cr | ₹1794 Cr | ₹1082 Cr | ₹854 Cr | ₹738 Cr |
| ₹891 Cr | ₹871 Cr | ₹653 Cr | ₹501 Cr | ₹381 Cr | ₹279 Cr | ₹188 Cr |
| ₹3 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2870 Cr | ₹2523 Cr | ₹1746 Cr | ₹1293 Cr | ₹701 Cr | ₹575 Cr | ₹551 Cr |
| ₹234 Cr | ₹144 Cr | ₹114 Cr | ₹98 Cr | ₹28 Cr | ₹11 Cr | ₹8 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹70 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹70 L |
| ₹108 Cr | ₹106 Cr | ₹93 Cr | ₹67 Cr | ₹55 Cr | ₹34 Cr | ₹35 Cr |
| ₹120 Cr | ₹69 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹3342 Cr | ₹2851 Cr | ₹1958 Cr | ₹1460 Cr | ₹785 Cr | ₹619 Cr | ₹594 Cr |
| — | — | — | — | — | — | — |
| ₹152 Cr | ₹264 Cr | ₹471 Cr | ₹34 Cr | ₹0 | ₹0 | ₹0 |
| ₹94 Cr | ₹80 Cr | ₹52 Cr | ₹36 Cr | ₹33 Cr | ₹28 Cr | ₹33 Cr |
| ₹161 Cr | ₹124 Cr | ₹97 Cr | ₹76 Cr | ₹57 Cr | ₹47 Cr | ₹52 Cr |
| ₹129 Cr | ₹251 Cr | ₹125 Cr | ₹149 Cr | ₹117 Cr | ₹65 Cr | ₹44 Cr |
| ₹13 Cr | ₹51 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹23 Cr | ₹19 Cr | ₹9 Cr | ₹9 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr |
| ₹573 Cr | ₹789 Cr | ₹759 Cr | ₹310 Cr | ₹227 Cr | ₹154 Cr | ₹146 Cr |
| ₹111 Cr | ₹311 Cr | ₹359 Cr | ₹9 Cr | ₹21 Cr | ₹4 Cr | -₹6 L |
| ₹3915 Cr | ₹3640 Cr | ₹2716 Cr | ₹1770 Cr | ₹1012 Cr | ₹774 Cr | ₹740 Cr |
| ₹64 | ₹59 | ₹1,429 | ₹792 | ₹310 | ₹269 | ₹363 |
| ₹64 | ₹59 | ₹48 | ₹26 | ₹10 | ₹9 | ₹12 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| ₹249 Cr | ₹160 Cr | ₹141 Cr | ₹84 Cr | ₹57 Cr | -₹48 Cr | -₹11 Cr |
| ₹373 Cr | ₹331 Cr | ₹233 Cr | ₹197 Cr | ₹138 Cr | ₹145 Cr | ₹139 Cr |
| -₹48 Cr | -₹98 Cr | ₹5 Cr | -₹13 Cr | -₹15 Cr | ₹10 Cr | -₹9 Cr |
| ₹574 Cr | ₹394 Cr | ₹378 Cr | ₹268 Cr | ₹180 Cr | ₹107 Cr | ₹120 Cr |
| ₹519 Cr | ₹357 Cr | ₹346 Cr | ₹233 Cr | ₹164 Cr | ₹99 Cr | ₹103 Cr |
| -₹308 Cr | -₹750 Cr | -₹914 Cr | -₹509 Cr | -₹155 Cr | -₹37 Cr | -₹80 Cr |
| -₹220 Cr | ₹382 Cr | ₹553 Cr | ₹303 Cr | ₹35 Cr | -₹37 Cr | -₹73 Cr |
| -₹10 Cr | -₹11 Cr | -₹15 Cr | ₹27 Cr | ₹44 Cr | ₹25 Cr | -₹50 Cr |
| ₹100 Cr | ₹112 Cr | ₹127 Cr | ₹100 Cr | ₹55 Cr | ₹39 Cr | ₹94 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹9 Cr | -₹6 Cr |
| ₹91 Cr | ₹100 Cr | ₹112 Cr | ₹127 Cr | ₹100 Cr | ₹55 Cr | ₹39 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 4 out of 9 oscillators
RSI
39.24Sell
STOCH %K
39.28Neutral
MACD Level(12,26)
-6.90Sell
Ultimate Oscillator
54.75Buy
Aroon Oscillator
-82.00Sell
BOP
0.33Buy
CCI
-156.60Buy
Williams %R
-60.72Neutral
Momentum
-22.70Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
484.08Sell
SMA 9
485.30Sell
EMA 21
491.77Sell
SMA 21
494.57Sell
EMA 50
494.86Sell
SMA 50
503.24Sell
EMA 200
475.29Buy
SMA 200
471.76Buy
WMA 20
488.67Sell
Pivot
Pivot
Classic
Resistance 5
553.03
Resistance 4
533.23
Resistance 3
513.43
Resistance 2
493.63
Resistance 1
482.32
Pivot
473.83
Support 1
462.52
Support 2
454.03
Support 3
434.23
Support 4
414.43
Support 5
394.63
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 32.33% | 32.34% | 32.36% | 32.39% | 32.42% | 32.42% |
| 34.52% | 37.91% | 37.87% | 37.97% | 38.02% | 39.15% |
| 1.68% | 1.70% | 1.96% | 2.01% | 2.07% | 1.53% |
| 14.18% | 6.02% | 5.87% | 5.77% | 5.85% | 4.91% |
| 17.29% | 22.03% | 21.94% | 21.86% | 21.64% | 21.99% |
Bulk & block deals
Name
Icici Prudential Mutual Fund
Polar Capital Funds Plc-Healthcare Opportunities Fund
Invesco Mutual Fund
Marwadi Chandarana Intermediaries Brokers Private Limited
Allianz Global Investors Gmbh Acting On Behalf Of Allianz Eee Fonds
Hyperion Investments Pte. Ltd.
Claymore Investments (Mauritius) Pte.ltd.
Marwadi Chandarana Intermediaries Brokers Private Limited
Goldman Sachs Bank Europe Se - Odi
Goldman Sachs (Singapore) Pte - Odi
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 12 Aug 2026 | Purchase | 311.21 Cr | ₹501 | 62.12 L | Bulk | 1.959401 | NSE |
| 12 Aug 2026 | Purchase | 181.68 Cr | ₹501 | 36.26 L | Bulk | 1.143883 | NSE |
| 12 Aug 2026 | Purchase | 179.93 Cr | ₹504.64 | 35.65 L | Bulk | 1.124652 | NSE |
| 12 Aug 2026 | Purchase | 98.47 Cr | ₹502.46 | 19.60 L | Bulk | 0.618185 | NSE |
| 12 Aug 2026 | Purchase | 88.78 Cr | ₹501 | 17.72 L | Bulk | 0.558984 | NSE |
| 12 Aug 2026 | Sell | 1,210.49 Cr | ₹501.03 | 2.42 Cr | Bulk | 7.620821 | NSE |
| 12 Aug 2026 | Sell | 797.45 Cr | ₹501.54 | 1.59 Cr | Bulk | 5.015358 | NSE |
| 12 Aug 2026 | Sell | 33.25 Cr | ₹510.96 | 6.51 L | Bulk | 0.205285 | NSE |
| 02 Sep 2025 | Purchase | 71.65 Cr | ₹433.25 | 16.54 L | Bulk | 0.521637 | NSE |
| 02 Sep 2025 | Sell | 71.65 Cr | ₹433.25 | 16.54 L | Bulk | 0.521637 | NSE |
Insider trading & SAST
Client name
Claymore Investments (Mauritius) Pte Ltd
Icici Prudential Mutual Fund
Invesco Mutual Fund
Hyperion Investments Pte Ltd
Dr. Anosh Agarwal
Dr Athiya Agarwal
Dr Athiya Agarwal
Dr. Athiya Agarwal
Dr. Athiya Agarwal
Dr Anosh Agarwal
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 Aug 2026 | Other | Disposal | 5.02 | 15.04 | 0 | — | 1.59 Cr | 12 Aug 2026 | Market | 4,76,71,770 | SAST | 29(2) | — |
| 26 Aug 2026 | Other | Acquisition | 5.36 | 5.36 | 0 | — | 1.70 Cr | 12 Aug 2026 | Market | 1,69,99,999 | SAST | 29(1) | — |
| 26 Aug 2026 | Other | Acquisition | 2.18 | 5.21 | 0 | — | 69.38 L | 12 Aug 2026 | Market | 1,65,25,136 | SAST | 29(1) | — |
| 26 Aug 2026 | Other | Disposal | 7.62 | 15.47 | 0 | — | 2.42 Cr | 12 Aug 2026 | Market | 4,90,33,988 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Disposal | 0.67 | 4.69 | 0 | — | 21.15 L | 04 Mar 2026 | Off Market / Inter se transfer | 1,48,57,920 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.45 | 4.45 | 0 | — | 14.42 L | 19 Mar 2026 | Off Market / Inter se transfer | 1,41,03,543 | SAST | 29(2) | — |
| 13 Apr 2026 | Other | Acquisition | 0.67 | — | 0 | — | 21.15 L | 04 Mar 2026 | - | — | SAST | 10(6) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.46 | — | 0 | — | 14.42 L | 13 Mar 2026 | — | — | SAST | 10(5) | — |
| 13 Apr 2026 | Promoter | Acquisition | 0.67 | 4 | 0 | — | 21.15 L | 04 Mar 2026 | Off Market / Inter se transfer | 1,26,61,975 | SAST | 29(2) | — |
| 13 Apr 2026 | Promoter | Disposal | 0.45 | 4.23 | 0 | — | 14.42 L | 19 Mar 2026 | Off Market / Inter se transfer | 1,34,16,352 | SAST | 29(2) | — |
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Dr. Agarwal's Health Care provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories,
Corporate Actions
Date
Type
Details
Company details
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Dr. Agarwal's Health Care Share Price
477.75+0.00 (+1.43%)
-10.73% past 1 Year
News
Dr. Agarwal's Health Care plans Delhi NCR expansion over next 2 to 3 years
Equity
AGARWALEYE
Dr Agarwal's Health Care to host analyst and investor meet on 16 September
Equity
AGARWALEYE
Dr. Agarwal Health Care reports higher Q1 EBITDA and margin
Equity
AGARWALEYE
Dr. Agarwal'S Health Care posts strong Q1 revenue growth on robust operations
Equity
AGARWALEYE
Dr. Agarwal's Health Care reports higher Q1 net profit year on year
Equity
AGARWALEYE
Dr. Agarwal'S Health Care to host Q1 FY27 earnings call on August 4
Equity
AGARWALEYE
Dr. Agarwal's Health Care’s arm invests $2,00,000 in Orbit Health Care ETH
Equity
AGARWALEYE
Dr. Agarwal's Health - Quaterly Results
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 10.60 Crores, in the March 2026 quarter
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about updates
Equity
AGARWALEYE
Dr. Agarwal's Health Care Terminates Idearx Associate Status Effective March 30, 2026, Retains 14.54% Stake.
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosures
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Morgan Stanley Maintains Overweight on Dr Agarwal’s Health Care with Rs 596 Target Price.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3 FY26 EBITDA Rises 27% YoY to Rs 140 Cr, Margin Expands to 27.17%.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3FY26 Net Profit Rises 51% YoY to Rs 33.70 Crores on 23% Revenue Growth.
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 14.06 Crores, in the December 2025 quarter
Equity
AGARWALEYE
Dr Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about investor presentation
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 4.68 Crores, in the September 2025 quarter
Equity
AGARWALEYE